Trial Profile
Protocol for ROTATEQ Post-Marketing Surveillance.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Rotavirus W179-9 vaccine (Primary)
- Indications Rotavirus infections
- Focus Adverse reactions
- Sponsors Merck & Co; Merck Sharp & Dohme
- 24 May 2011 New trial record